FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiovascular diseases, and can be used for estimation of severity of endothelial dysfunction in patients with rheumatoid arthritis. Essence of method is based on determination of complex of parameters, ranges (R) of values of which are used for assigning diagnostic coefficients (DC). After that, DC values are summed up to obtain value of diagnostic index (DI). If its value is lower or equals minus 50, absence of ED is determined, if its value is higher than minus 50 or equals 0, indefinite state is determined, if its value is higher than 0 and lower than 40, initial manifestations of ED are determined, if its value is higher or equals 40, expressed endothelial dysfunction is determined.
EFFECT: application of invention makes it possible to differentiate severity of endothelial dysfunction, specify tactics of patient managing and achieve higher therapeutic effect.
1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2022 |
|
RU2790525C1 |
METHOD OF VASOMOTOR ENDOTHELIAL DYSFUNCTION CORRECTION AND ARTERIAL RIGIDITY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2018 |
|
RU2696285C1 |
METHOD FOR PREDICTION OF EFFICACY OF INFLIXIMAB INCLUSION IN THERAPY OF PATIENTS WITH RHEUMATOID ARTHRITIS | 2010 |
|
RU2416799C1 |
DIAGNOSTIC TECHNIQUE FOR RHEUMATOID ARTHRITIS | 2014 |
|
RU2554755C1 |
DIAGNOSTIC TECHNIQUE FOR LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2009 |
|
RU2429785C2 |
METHOD FOR PREDICTING THE DEVELOPMENT OF THE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PATIENTS SUFFERING FROM ANKYLOSING SPONDYLITIS | 2022 |
|
RU2790770C1 |
DIAGNOSTIC TECHNIQUE FOR DEVELOPING ERECTILE DYSFUNCTION IN YOUNG MALES SUFFERING FROM ARTERIAL HYPERTENSION DEPENDING ON THE LEVEL OF TESTOSTERONE, LIPID SPECTRUM, ECHOCARDIOGRAPHIC INDICATORS | 2015 |
|
RU2601405C1 |
METHOD FOR ARTERIAL RIGIDITY CORRECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS | 2016 |
|
RU2623082C1 |
METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
METHOD FOR PREDICTION OF RISK OF RENAL VENOUS BLOOD FLOW DISTURBANCE IN PATIENTS WITH ARTERIAL HYPERTENSION | 2024 |
|
RU2824420C1 |
Authors
Dates
2014-12-20—Published
2013-07-25—Filed